Regulation of biocatalysis in industrial chemical processes

Introduction

Biocatalysis refers to the use of biological catalysts, such as enzymes, microorganisms or isolated cells, to accelerate chemical reactions in industrial manufacturing. It is widely used in pharmaceuticals, food processing, textiles, biofuels, detergents and fine chemicals. Compared with conventional chemical catalysts, biocatalysts can operate under relatively mild conditions, improve reaction selectivity and reduce certain forms of chemical waste.

However, industrial biocatalysis raises regulatory concerns involving biosafety, genetically modified organisms, environmental pollution, worker protection, product quality and intellectual property. In India, there is no single legislation exclusively governing industrial biocatalysis. Its regulation is determined by the nature of the biological catalyst, the manufacturing process and the final product.

Legal framework in India

The Environment (Protection) Act, 1986 is a major legislative instrument governing industrial activities that may affect the environment. It empowers the Central Government to prescribe environmental standards, regulate hazardous substances and take preventive measures against pollution.

The Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells, 1989, commonly known as the Rules for Genetic Engineering, are particularly relevant where industrial biocatalysis involves genetically engineered microorganisms or cells. These Rules establish regulatory authorities and procedures for handling specified biological materials.

Important regulatory bodies include:

Institutional Biosafety Committee (IBSC): Supervises biotechnology activities at the institutional level.

Review Committee on Genetic Manipulation (RCGM): Monitors research involving genetically engineered organisms and related activities within its jurisdiction.

Genetic Engineering Appraisal Committee (GEAC): Considers specified activities involving large-scale use and environmental release of genetically engineered organisms.

State Biotechnology Coordination Committee (SBCC): Monitors compliance with applicable biotechnology regulations at the state level.

Where industrial biocatalysis uses ordinary, non-genetically modified enzymes, the 1989 Rules may not apply merely because an enzyme is biological in origin. Their applicability depends on whether the activity involves organisms or materials covered by the Rules.

Environmental and industrial regulation

Industrial biocatalysis may generate wastewater, biological residues, solvents and other manufacturing waste. The Water (Prevention and Control of Pollution) Act, 1974 regulates the discharge of industrial effluents, while the Air (Prevention and Control of Pollution) Act, 1981 controls industrial air pollution.

The Hazardous and Other Wastes (Management and Transboundary Movement) Rules, 2016 may apply where industrial processes generate waste falling within their categories. Facilities must comply with applicable authorisation, storage, treatment and disposal requirements.

The Factories Act, 1948, together with applicable state factory rules and occupational-safety requirements, has traditionally governed workplace health and safety. The implementation of the Occupational Safety, Health and Working Conditions Code, 2020 must also be considered in light of its commencement and applicable notifications.

Product safety and quality standards

Biocatalysts used in food, pharmaceutical and cosmetic manufacturing are subject to product-specific requirements.

Under the Food Safety and Standards Act, 2006, food-processing operations must comply with applicable food-safety standards and regulatory requirements. Enzymes used in food manufacturing must meet relevant safety and quality conditions.

Pharmaceutical manufacturing involving biocatalysis must comply with the Drugs and Cosmetics Act, 1940, applicable rules and relevant Good Manufacturing Practices. Manufacturers must validate the process, control impurities and maintain consistent product quality.

The use of genetically engineered production organisms may additionally trigger biosafety requirements under the 1989 Rules.

Intellectual property and commercial regulation

Industrial biocatalysis often involves proprietary enzymes, engineered microorganisms, manufacturing methods and specialised reaction conditions. The Patents Act, 1970 provides protection for qualifying inventions.

However, Section 3(j) excludes plants and animals, in whole or any part thereof, other than microorganisms, from patentability. Essentially biological processes for the production or propagation of plants and animals are also excluded. Section 3(c) excludes the mere discovery of a scientific principle or naturally occurring living or non-living substance.

Consequently, a technically innovative enzyme application or industrial process may qualify for patent protection if it satisfies the requirements of novelty, inventive step and industrial applicability and does not fall within statutory exclusions.

Important case laws

1. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court emphasised the importance of scientific expertise in environmental decision-making. It recognised that environmental disputes involving complex technical questions require informed scientific assessment. This principle is relevant when authorities evaluate industrial biocatalysis processes involving biological risks, effluent treatment or environmental impacts.

2. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognised the precautionary principle and polluter-pays principle as essential features of Indian environmental law. These principles require industrial operators to prevent environmental damage and bear responsibility for pollution caused by their activities. They are relevant to biocatalysis facilities handling biological materials and generating industrial waste.

3. Indian Council for Enviro-Legal Action v. Union of India (1996)

The Supreme Court held that industries responsible for environmental contamination could be required to pay the costs of remediation. The decision reinforces the principle that industrial biotechnology companies must manage waste responsibly and cannot transfer environmental-cleanup costs to the public.

4. M.C. Mehta v. Union of India (Oleum Gas Leak Case, 1987)

The Supreme Court established the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities. Although the case did not concern biocatalysis, its principles may apply to industrial facilities where hazardous biological or chemical processes create serious risks to workers or surrounding communities.

5. Novozymes A/S v. Assistant Controller of Patents and Designs (2023)

Patent disputes involving enzyme-related inventions illustrate the importance of satisfying statutory patentability requirements, particularly inventive step and sufficient disclosure. Such disputes are relevant to industrial biocatalysis because companies frequently seek patent protection for improved enzymes and enzyme-based processes. Patent protection remains dependent on the particular invention and the applicable provisions of the Patents Act.

Regulatory challenges and future developments

The principal challenges include uncertainty over the classification of novel enzymes, inadequate specialised biosafety infrastructure, management of genetically engineered production organisms and protection of proprietary biological technologies.

India should strengthen regulatory coordination between environmental authorities, biotechnology regulators, food-safety agencies and pharmaceutical regulators. Risk-based approvals, standardised biosafety assessments, transparent waste-management procedures and regular industrial inspections would improve compliance.

Conclusion

Regulation of biocatalysis in industrial chemical processes in India involves environmental legislation, biotechnology biosafety rules, product-quality standards, workplace-safety requirements and intellectual property law. The 1989 Rules are especially important when genetically engineered microorganisms or cells are involved, while environmental and product-specific laws govern other aspects of industrial production. Although Indian courts have not developed a substantial body of case law specifically concerning industrial biocatalysis, decisions such as Vellore Citizens' Welfare Forum, A.P. Pollution Control Board and M.C. Mehta provide important principles of precaution, scientific assessment and industrial responsibility. A coordinated, risk-based regulatory framework is essential for promoting safe and sustainable industrial biocatalysis.